Trial · NCT02783300
Results by group4,790
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 4,790
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Part 1: Number of Participants With Any Adverse Events (AEs) and Serious Adverse Events (SAEs) | Part 1: GSK3326595 12.5 Milligram (mg) Once a Day (QD) | Any AEs | 1 | Participants | |
| Part 1: Number of Participants With Any Adverse Events (AEs) and Serious Adverse Events (SAEs) | Part 1: GSK3326595 25mg QD | Any AEs | 1 | Participants | |
| Part 1: Number of Participants With Any Adverse Events (AEs) and Serious Adverse Events (SAEs) | Part 1: GSK3326595 50mg QD | Any AEs | 1 | Participants | |
| Part 1: Number of Participants With Any Adverse Events (AEs) and Serious Adverse Events (SAEs) | Part 1: GSK3326595 100mg QD | Any AEs | 1 | Participants | |
| Part 1: Number of Participants With Any Adverse Events (AEs) and Serious Adverse Events (SAEs) | Part 1: GSK3326595 200mg QD | Any AEs | 7 | Participants | |
| Part 1: Number of Participants With Any Adverse Events (AEs) and Serious Adverse Events (SAEs) | Part 1: GSK3326595 300mg QD | Any AEs | 3 | Participants | |
| Part 1: Number of Participants With Any Adverse Events (AEs) and Serious Adverse Events (SAEs) | Part 1: GSK3326595 400mg QD | Any AEs | 19 | Participants | |
| Part 1: Number of Participants With Any Adverse Events (AEs) and Serious Adverse Events (SAEs) | Part 1: GSK3326595 600mg QD | Any AEs | 3 | Participants | |
| Part 1: Number of Participants With Any Adverse Events (AEs) and Serious Adverse Events (SAEs) | Part 1: GSK3326595 50mg Twice Daily (BID) | Any AEs | 1 | Participants | |
| Part 1: Number of Participants With Any Adverse Events (AEs) and Serious Adverse Events (SAEs) | Part 1: GSK3326595 100mg BID | Any AEs | 7 | Participants | |
| Part 1: Number of Participants With Any Adverse Events (AEs) and Serious Adverse Events (SAEs) | Part 1: GSK3326595 150mg BID | Any AEs | 6 | Participants | |
| Part 1: Number of Participants With Any Adverse Events (AEs) and Serious Adverse Events (SAEs) | Part 1: GSK3326595 200mg BID | Any AEs | 3 | Participants | |
| Part 1: Number of Participants With Any Adverse Events (AEs) and Serious Adverse Events (SAEs) | Part 1: GSK3326595 300mg QD (Food Effect) | Any AEs | 15 | Participants | |
| Part 1: Number of Participants With Any Adverse Events (AEs) and Serious Adverse Events (SAEs) | Part 1: GSK3326595 12.5 Milligram (mg) Once a Day (QD) | Any SAEs | 0 | Participants | |
| Part 1: Number of Participants With Any Adverse Events (AEs) and Serious Adverse Events (SAEs) | Part 1: GSK3326595 25mg QD | Any SAEs | 0 | Participants | |
| Part 1: Number of Participants With Any Adverse Events (AEs) and Serious Adverse Events (SAEs) | Part 1: GSK3326595 50mg QD | Any SAEs | 0 | Participants | |
| Part 1: Number of Participants With Any Adverse Events (AEs) and Serious Adverse Events (SAEs) | Part 1: GSK3326595 100mg QD | Any SAEs | 0 | Participants | |
| Part 1: Number of Participants With Any Adverse Events (AEs) and Serious Adverse Events (SAEs) | Part 1: GSK3326595 200mg QD | Any SAEs | 4 | Participants | |
| Part 1: Number of Participants With Any Adverse Events (AEs) and Serious Adverse Events (SAEs) | Part 1: GSK3326595 300mg QD | Any SAEs | 1 | Participants | |
| Part 1: Number of Participants With Any Adverse Events (AEs) and Serious Adverse Events (SAEs) | Part 1: GSK3326595 400mg QD | Any SAEs | 10 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02783300/results